BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1507451)

  • 1. [Survey of MRSA infection in Ibaraki-ken--Ibaraki Association for infectious diseases].
    Hasegawa S; Yoshizawa Y; Nakai T; Sawahata T; Ishida H; Irokawa M; Iwata S; Goto A; Shinohara Y; Togawa S
    Nihon Rinsho; 1992 May; 50(5):961-9. PubMed ID: 1507451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
    Brown PD; Ngeno C
    Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE; Al-Sweih N; Dhar R; Dimitrov TS; Mokaddas EM; Johny M; Al-Obaid IA; Gomaa HH; Mobasher LA; Rotimi VO; Al-Asar A
    Med Princ Pract; 2008; 17(1):71-5. PubMed ID: 18059105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
    Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
    Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation of methicillin-resistant Staphylococcus aureus (MRSA) at the Hokusho Central Hospital--observation during the recent 4 years].
    Mukae H; Iwamoto M; Takase T; Moro N; Ishino T; Doutsu Y; Kouno S; Yamaguchi K; Hirota M; Hara K
    Kansenshogaku Zasshi; 1990 Oct; 64(10):1275-86. PubMed ID: 2258644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) at Kumamoto University Hospital].
    Tosaka M; Yamane N; Okabe H
    Nihon Rinsho; 1992 May; 50(5):975-80. PubMed ID: 1507453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
    Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
    Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
    Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I
    Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T; Araake M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
    LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
    Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus].
    Akiyama H; Yamada T; Shimoe K; Torigoe R; Kanzaki H; Arata J
    Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(12):1257-61. PubMed ID: 2077154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility and clonal relatedness between community- and hospital-acquired methicillin-resistant Staphylococcus aureus from blood cultures.
    Jung SI; Shin DH; Park KH; Shin JH
    J Microbiol; 2006 Jun; 44(3):336-43. PubMed ID: 16820764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance among clinical isolates of Staphylococcus aureus in Thailand from 2000 to 2005.
    Tishyadhigama P; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Piboonbanakit D
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S8-18. PubMed ID: 21298843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MRSA respiratory tract infection].
    Shishido H; Nagai H; Kawakami K
    Nihon Rinsho; 1992 May; 50(5):1075-80. PubMed ID: 1507430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.